Robert Moot
Impact in
-
- CAR-T cell therapy research
-
- Hemophilia Treatment and Research
Papers in
- Oncology 7
- CAR-T cell therapy research 7
-
- CRISPR and Genetic Engineering 4
- Co-authors
- H. Trent Spencer (10 shared papers)Christopher B. Doering (10 shared papers)Sunil S. Raikar (4 shared papers)Andrew Fedanov (1 shared paper)Neal N. Iwakoshi (1 shared paper)Evan Colletti (2 shared papers)Graça Almeida‐Porada (2 shared papers)Christopher D. Porada (2 shared papers)
- Journals
- Blood (4 papers)Cancer Research (2 papers)Molecular Therapy — Oncolytics (1 paper)Biomicrofluidics (1 paper)OncoImmunology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert Moot
12 papers receiving 225 citations
Peers
Comparison fields: 5 of 34
- Oncology 144
- Hematology 53
- Genetics 98
- Genetics 31
- Immunology 54
Countries citing papers authored by Robert Moot
This map shows the geographic impact of Robert Moot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Moot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Moot more than expected).
Fields of papers citing papers by Robert Moot
This network shows the impact of papers produced by Robert Moot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Moot. The network helps show where Robert Moot may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Moot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 68 | |
| 2 | 2011 | 52 | |
| 3 | 2010 | 36 | |
| 4 | 2016 | 27 | |
| 5 | 2014 | 18 | |
| 6 | 2017 | 9 | |
| 7 | 2014 | 8 | |
| 8 | 2015 | 4 | |
| 9 | 2010 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2015 | 2 | |
| 12 | 2019 | 1 |
About Robert Moot
Robert Moot is a scholar working on Oncology, Molecular Biology, Genetics, Hematology and Immunology, having authored 12 papers that have together received 230 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (4 papers), CRISPR and Genetic Engineering (4 papers), Hemophilia Treatment and Research (3 papers), Immune Cell Function and Interaction (2 papers), Nanowire Synthesis and Applications (1 paper), Cancer Research and Treatments (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (144 citations), Hematology (53 citations), Genetics (98 citations), Genetics (31 citations) and Immunology (54 citations). Robert Moot has collaborated with scholars based in United States. Frequent co-authors include H. Trent Spencer, Christopher B. Doering, Sunil S. Raikar, Andrew Fedanov, Neal N. Iwakoshi, Evan Colletti, Graça Almeida‐Porada, Christopher D. Porada, Bagirath Gangadharan and Chad Sanada. Their work appears in journals such as Blood, Cancer Research, Molecular Therapy — Oncolytics, Biomicrofluidics and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.